E M Mandel

Summary

Affiliation: Children's Hospital of Pittsburgh
Country: USA

Publications

  1. ncbi Efficacy of ceftibuten compared with amoxicillin for otitis media with effusion in infants and children
    E M Mandel
    Department of Pediatric Otolaryngology, Children s Hospital of Pittsburgh, PA 15213 2583, USA
    Pediatr Infect Dis J 15:409-14. 1996
  2. ncbi Efficacy of antimicrobial prophylaxis for recurrent middle ear effusion
    E M Mandel
    Department of Otolaryngology, Children s Hospital of Pittsburgh, PA 15213 2583, USA
    Pediatr Infect Dis J 15:1074-82. 1996
  3. ncbi The heritability of otitis media: a twin and triplet study
    M L Casselbrant
    Department of Otolaryngology, University of Pittsburgh School of Medicine, Children s Hospital of Pittsburgh, PA 15213, USA
    JAMA 282:2125-30. 1999
  4. ncbi Comparative efficacy of erythromycin-sulfisoxazole, cefaclor, amoxicillin or placebo for otitis media with effusion in children
    E M Mandel
    Department of Pediatric Otolaryngology, Children s Hospital of Pittsburgh, PA 15213
    Pediatr Infect Dis J 10:899-906. 1991
  5. ncbi The genetics of otitis media
    M L Casselbrant
    Department of Pediatric Otolaryngology, Children s Hospital of Pittsburgh, Departments of Otolaryngology and Pediatrics, University of Pittsburgh School of Medicine, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA
    Curr Allergy Asthma Rep 1:353-7. 2001
  6. ncbi Antibiotics for otitis media with effusion
    E M Mandel
    ENT Research Center, Children s Hospital of Pittsburgh, Pittsburgh, PA 15213, USA
    Minerva Pediatr 56:481-95. 2004

Detail Information

Publications6

  1. ncbi Efficacy of ceftibuten compared with amoxicillin for otitis media with effusion in infants and children
    E M Mandel
    Department of Pediatric Otolaryngology, Children s Hospital of Pittsburgh, PA 15213 2583, USA
    Pediatr Infect Dis J 15:409-14. 1996
    ..This trial compared the efficacy of ceftibuten with that of amoxicillin in resolving otitis media with effusion...
  2. ncbi Efficacy of antimicrobial prophylaxis for recurrent middle ear effusion
    E M Mandel
    Department of Otolaryngology, Children s Hospital of Pittsburgh, PA 15213 2583, USA
    Pediatr Infect Dis J 15:1074-82. 1996
    ..This trial compared the efficacy of amoxicillin prophylaxis with that of placebo for the management of recurrent middle ear effusion (MEE) in children...
  3. ncbi The heritability of otitis media: a twin and triplet study
    M L Casselbrant
    Department of Otolaryngology, University of Pittsburgh School of Medicine, Children s Hospital of Pittsburgh, PA 15213, USA
    JAMA 282:2125-30. 1999
    ..Anatomical, physiological, and epidemiological data indicate that there may be a significant genetic component to prolonged time with and recurrent episodes of otitis media in children...
  4. ncbi Comparative efficacy of erythromycin-sulfisoxazole, cefaclor, amoxicillin or placebo for otitis media with effusion in children
    E M Mandel
    Department of Pediatric Otolaryngology, Children s Hospital of Pittsburgh, PA 15213
    Pediatr Infect Dis J 10:899-906. 1991
    ..14.1%, P = 0.007), but not at 4 weeks. We conclude that when antimicrobial treatment for otitis media with effusion is deemed advisable, neither erythromycin-sulfisoxazole nor cefaclor should replace amoxicillin as first line treatment...
  5. ncbi The genetics of otitis media
    M L Casselbrant
    Department of Pediatric Otolaryngology, Children s Hospital of Pittsburgh, Departments of Otolaryngology and Pediatrics, University of Pittsburgh School of Medicine, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA
    Curr Allergy Asthma Rep 1:353-7. 2001
    ....
  6. ncbi Antibiotics for otitis media with effusion
    E M Mandel
    ENT Research Center, Children s Hospital of Pittsburgh, Pittsburgh, PA 15213, USA
    Minerva Pediatr 56:481-95. 2004
    ..Also, antimicrobial therapy may provide at least short-term relief for symptomatic children (hearing loss, developmental delay, etc.) for whom surgery must be postponed or is contraindicated...